PTSD Treatment in Sarasota: What Interventional Psychiatry Offers When Standard Care Falls Short

Post-traumatic stress disorder affects roughly 3.5 percent of adults in the United States each year, yet a significant proportion of those who seek treatment do not achieve full symptom remission through first-line therapies. For patients who have worked through standard care and still find themselves cycling through intrusive memories, hypervigilance, and emotional numbness, the question of what comes next deserves a direct answer.

What PTSD Is and Why It Resists Standard Treatment

Post-traumatic stress disorder — PTSD — is a psychiatric condition that can develop after exposure to a traumatic event involving actual or threatened death, serious injury, or sexual violence. Mayo Clinic describes the condition’s hallmark symptoms as intrusive re-experiencing of the traumatic event, persistent avoidance of reminders, negative changes in mood and cognition, and marked changes in arousal and reactivity (Mayo Clinic). These symptom clusters can become deeply entrenched, and the neurological underpinning of PTSD — particularly the role of the amygdala in encoding and retrieving fear-based memories — helps explain why it can be so resistant to resolution.

The amygdala, a brain structure centrally involved in fear processing and stress response, plays a direct role in how PTSD symptoms are maintained. Research on the amygdala’s role in fear and stress responses provides a neurological basis for understanding how trauma-related memories become dysregulated and self-reinforcing (National Center for Biotechnology Information). When the fear-memory cycle is deeply encoded, standard therapeutic approaches — even evidence-based ones — can run up against a wall.

First-line treatments for PTSD include cognitive behavioral therapy (CBT) with a trauma focus, prolonged exposure therapy, and EMDR, alongside certain medications. The American Psychological Association identifies CBT as a gold-standard, evidence-based approach for PTSD, and it helps many patients significantly (American Psychological Association). But adequate response is not universal, and patients who have worked through these approaches without achieving full remission are not simply non-responders — they are candidates for a more advanced clinical look.

What Interventional Psychiatry Adds

At Cohen & Associates, we approach treatment-resistant PTSD with the same framework we apply to treatment-resistant depression: the history of what has not worked is clinical information, and it points toward mechanisms that standard care has not fully addressed.

Ketamine-assisted psychotherapy — KAP — is the primary interventional option we offer for PTSD that has not responded adequately to conventional treatment. Ketamine acts on NMDA receptors (specialized protein structures in the brain involved in learning and memory consolidation), producing rapid reductions in PTSD symptom severity in patients for whom other treatments have fallen short (National Center for Biotechnology Information). Research supports significant and rapid reductions in PTSD symptoms including intrusive memories and hyperarousal following ketamine treatment (National Center for Biotechnology Information).

What distinguishes our approach from standalone ketamine treatment is the psychotherapy integration. At Cohen & Associates, KAP is delivered by Teri Callender, LCSW, PA-C, a psychiatric physician assistant and licensed clinical social worker who holds specific certification in ketamine-assisted psychotherapy. The ketamine component creates a period of heightened neuroplasticity — a window in which the brain is temporarily more receptive to forming new patterns — and structured psychotherapy is designed to work within that window. For patients with PTSD, this may mean processing traumatic material that has previously been inaccessible or unbearable in conventional therapy sessions.

Individual psychotherapy, separate from KAP, is also available at our practice through Teri Callender and Angelo Domingo, PsyD. For some patients, psychotherapy is the appropriate primary treatment; for others it works alongside KAP or medication management. We do not apply a single protocol — the treatment plan follows from a thorough evaluation.

The Evaluation Process for PTSD

Before any treatment is recommended, we conduct a comprehensive psychiatric evaluation that examines your full history: prior treatments, medication trials, trauma background, and current symptom presentation. PTSD frequently co-occurs with depression, anxiety, and substance use, and a complete assessment looks at the full picture rather than the PTSD diagnosis in isolation.

Dr. Rebecca Cohen and Dr. Robin Bixler bring clinical experience with complex psychiatric presentations to the evaluation process. Medication management may be part of the treatment plan — some medications have evidence for PTSD symptom reduction, and a psychopharmacologist’s review of your history can identify options that have not been fully explored. In some cases, genetic testing can clarify why prior medications have not worked as expected.

Results vary by individual. PTSD treatment, even with advanced options, is a process — not a single intervention. We discuss realistic expectations at every stage and adjust the treatment plan as you respond.

Barriers to Care and How We Address Them

Two barriers come up consistently for patients seeking PTSD treatment: stigma around disclosure and uncertainty about cost.

Disclosing a trauma history to a new provider is not a small thing, and we do not treat it as one. Our evaluation process is structured to be collaborative and unhurried. We understand that patients presenting with treatment-resistant PTSD have typically already navigated multiple providers and multiple attempts at care, and that history shapes how much trust is available at the start of a new clinical relationship. We approach it accordingly.

On cost: we operate on a direct-care model, which means we do not bill insurance directly and do not accept insurance payments at the time of service. Patients pay by debit/credit card, check, or cash. Visits may be partially covered as out-of-network psychiatric care, and we provide invoices for patient-submitted reimbursement on request. The amount reimbursed depends on your specific plan. We discuss costs transparently during the initial consultation, before any treatment commitment is made. Pricing for individual services is not listed on our website; that conversation happens directly.

In-person appointments are available Monday through Thursday from 9 AM to 5 PM and Friday from 9 AM to 1 PM. Telehealth is available for appropriate aspects of care.

FAQ

Does ketamine-assisted psychotherapy work for PTSD specifically, or only depression?

KAP has clinical evidence supporting its use for PTSD. Research documents significant, rapid reductions in PTSD symptom severity following ketamine treatment, including in patients with chronic and treatment-resistant presentations. At Cohen & Associates, PTSD is a confirmed condition for which we offer KAP after a thorough evaluation establishes candidacy.

I’ve already tried trauma-focused CBT. Does that disqualify me from KAP?

No. Prior CBT or other therapy — even multiple courses — does not disqualify you from KAP. A history of prior treatment is part of the evaluation, and for many patients with treatment-resistant PTSD, it is precisely that history that makes KAP a clinically appropriate next step. Discuss your full treatment history during your evaluation.

Is PTSD treatment at Cohen & Associates only for combat veterans?

No. PTSD can develop following any type of traumatic experience — accident, assault, medical trauma, childhood trauma, loss, or witnessing harm to others. Our practice treats adults with PTSD across all backgrounds and trauma types.

What medications are typically used for PTSD, and do you prescribe them?

Certain antidepressants have evidence for PTSD symptom reduction. Dr. Cohen and Dr. Bixler both conduct psychiatric evaluations and manage medications, including for PTSD. Medication management may be part of your treatment plan alongside psychotherapy or KAP, depending on your evaluation. Discuss your current medications and prior medication history during your first appointment.

How do I start the process?

Call our office at 941-559-8500 or use our online contact form to schedule a new patient evaluation. No referral is required. Bring whatever documentation you have about prior treatments — it helps us conduct a more thorough evaluation from the start.

Key Takeaways

• PTSD is driven in part by dysregulated fear-memory processing involving the amygdala, which helps explain why some patients do not achieve full remission through standard therapy or medication.
• Ketamine-assisted psychotherapy is clinically supported for treatment-resistant PTSD, producing rapid reductions in symptom severity through a mechanism distinct from conventional treatments.
• At Cohen & Associates, KAP is delivered by a KAP-certified provider within a structured psychotherapy framework — the integration is built into the treatment, not offered as an add-on.
• Individual psychotherapy, medication management, and pharmacogenomic evaluation are all available within our practice for a coordinated care approach.
• Results vary by individual; a comprehensive psychiatric evaluation is the essential first step before any treatment recommendation is made.

For patients with PTSD who have put real effort into standard care and still do not have the relief they need, our evaluation process is designed to take that history seriously and assess what it suggests about next steps. Call us at 941-559-8500 or use our online contact form to schedule a new patient evaluation at our Sarasota office.

References

1. Mayo Clinic. Symptoms and causes of post-traumatic stress disorder. https://www.mayoclinic.org/diseases-conditions/post-traumatic-stress-disorder/symptoms-causes/syc-20355967
2. National Center for Biotechnology Information. Ketamine for PTSD. https://pmc.ncbi.nlm.nih.gov/articles/PMC10979792/
3. National Center for Biotechnology Information. Fear, stress, and the amygdala. https://pmc.ncbi.nlm.nih.gov/articles/PMC2882379/
4. American Psychological Association. Cognitive behavioral therapy for PTSD. https://www.apa.org/ptsd-guideline/patients-and-families/cognitive-behavioral

Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. PTSD treatment, including ketamine-assisted psychotherapy and other advanced psychiatric interventions, should only be pursued under the supervision of a licensed psychiatric provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.